|
2025
|
P/S
|
Vaccines for the treatment and prevention of Covid-19 |
|
|
P/S
|
Providing medical and scientific research information in the field of Covid-19 vaccines, and clin... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants for med... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of infectious
diseases; vaccines; adjuvants for me... |
|
|
Invention
|
Pneumococcal conjugate vaccines with saponin-based adjuvants.
The invention is directed to an im... |
|
|
Invention
|
Pneumococcal conjugate vaccines with saponin-based adjuvants. The invention is directed to an imm... |
|
|
P/S
|
Pharmaceutical, biologic, and vaccine research and development; consulting services in the field ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of infectious diseases; Vaccines; Adjuvants for med... |
|
|
Invention
|
Avian influenza nanoparticle immunogenic compositions. An influenza vaccine nanoparticle includes... |
|
|
Invention
|
Avian influenza nanoparticle immunogenic compositions.
An influenza vaccine nanoparticle include... |
|
|
P/S
|
Vaccines. Providing medical and scientific research information in the field of vaccines, biomedi... |
|
2024
|
Invention
|
Intranasal immunogenic compositions. Disclosed herein are intranasal immunogenic compositions com... |
|
|
Invention
|
Intranasal immunogenic compositions.
Disclosed herein are intranasal immunogenic compositions co... |
|
|
Invention
|
Saponin-based adjuvants and methods of characterizing same. Immunogenic compositions that include... |
|
|
Invention
|
Anti-sars-cov-2 spike (s) antibodies and their use in treating covid-19.
The present invention p... |
|
|
Invention
|
Anti-sars-cov-2 spike (s) antibodies and their use in treating covid-19. The present invention pr... |
|
|
Invention
|
Method for detecting anti-sars-cov-2 spike (s) immunoglobulins. Disclosed are methods for detecti... |
|
|
Invention
|
Method for detecting anti-sars-cov-2 spike (s) immunoglobulins.
Disclosed are methods for detect... |
|
|
Invention
|
Methods and compositions for treating respiratory disease.
Disclosed herein are methods and nano... |
|
|
Invention
|
Sars-cov-2 vaccine compositions.
Disclosed herein are coronavirus (CoV) Spike(S) polypeptides, i... |
|
|
Invention
|
Sars-cov-2 vaccine compositions. Disclosed herein are coronavirus (CoV) Spike (S) polypeptides, i... |
|
|
Invention
|
Coronavirus and influenza compositions and methods for using them. An immunogenic composition for... |
|
|
Invention
|
Coronavirus and influenza compositions and methods for using them.
An immunogenic composition fo... |
|
|
Invention
|
Rsv f vaccine formulations. Disclosed herein are RSV F glycoproteins and nanoparticles comprising... |
|
|
Invention
|
Multivalent influenza nanoparticle vaccines.
Disclosed herein are multivalent nanoparticle vacci... |
|
2023
|
Invention
|
Coronavirus vaccine formulations. Disclosed herein are coronavirus Spike (S) proteins and nanopar... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of infectious diseases and vaccine preparations and... |
|
|
Invention
|
Downstream process for purification of viral proteins with hydrophobic membrane domain for use in... |
|
|
Invention
|
Pseudovirus based neutralization assay for evaluating vaccine immunogenicity.
Provided herein ar... |
|
|
Invention
|
Ace2 inhibition assay for evaluation of vaccine immunogenicity. An improved assay to measure immu... |
|
|
Invention
|
Pseudovirus based neutralization assay for evaluating vaccine immunogenicity. Provided herein are... |
|
|
P/S
|
Vaccines for human use Providing medical and scientific research information in the field of vacc... |
|
|
P/S
|
Vaccines. Providing medical and scientific research information in the
field of vaccines, biomed... |
|
|
P/S
|
Vaccines Providing medical and scientific research information in the field of vaccines, biomedic... |
|
|
Invention
|
Compositions and methods for inducing an immune response against epstein-barr virus.
Provided he... |
|
|
Invention
|
Compositions and methods for inducing an immune response against epstein-barr virus. Provided her... |
|
2022
|
Invention
|
Anti-sars-cov-2 spike (s) antibodies and their use in treating covid-19.
Infectious diseases rem... |
|
|
Invention
|
Anti-sars-cov-2 spike (s) antibodies and their use in treating covid-19. Infectious diseases rema... |
|
|
Invention
|
Coronavirus vaccine formulations.
Disclosed herein are coronavirus Spike (S) proteins and nanopa... |
|
|
Invention
|
Methods and compositions for treating and preventing malaria.
The present disclosure provides im... |
|
|
Invention
|
Methods and compositions for treating and preventing malaria. The present disclosure provides imm... |
|
|
P/S
|
Providing medical and scientific research information in the field of vaccines, biomedicine, clin... |
|
|
P/S
|
Vaccines |
|
|
Invention
|
Malaria vaccine formulations.
Disclosed herein are immunogenic compositions comprising an antige... |
|
|
Invention
|
Malaria vaccine formulations. Plasmodium Plasmodium parasite. Methods of administering the aforem... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants. Pharma... |
|
|
Invention
|
Modified rsv f proteins and methods of their use. The present invention is generally related to m... |
|
|
P/S
|
Vaccines. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of infectious diseases, namely, Covid-19, malaria, ... |
|
|
P/S
|
Pharmaceutical, biologic, and vaccine research and
development; consulting services in the field... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of infectious
diseases; vaccines; adjuvants. Pharm... |
|
|
Invention
|
Vaccine compositions having improved stability and immunogenicity. Disclosed herein are nanoparti... |
|
|
Invention
|
Coronavirus and influenza compositions and methods for using them.
Disclosed herein are composit... |
|
|
Invention
|
Coronavirus and influenza compositions and methods for using them. Disclosed herein are compositi... |
|
|
Invention
|
Corona virus vaccine formulations. Disclosed herein are coronavirus Spike (S) proteins and nanopa... |
|
2021
|
P/S
|
Vaccines for the treatment and prevention of Covid-19. Providing medical and scientific research ... |
|
|
Invention
|
Multivalent influenza nanoparticle vaccines. Disclosed herein are multivalent nanoparticle vaccin... |
|
|
Invention
|
Clostridium difficile. C. difficile infection. In particular aspects, the compositions are vaccin... |
|
|
P/S
|
Human vaccines; vaccine adjuvants; pharmaceutical preparations for the treatment of infectious di... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of infectious
diseases, biologic preparations for ... |
|
2020
|
P/S
|
Human vaccines |
|
|
Invention
|
Methods for preventing disease or disorder caused by rsv infection.
The present invention is gen... |
|
2018
|
Invention
|
Methods and compositions for treating respiratory disease. Disclosed herein are methods and nanop... |
|
2017
|
P/S
|
Human vaccines; vaccine adjuvants Pharmaceutical, biologic, and vaccine research and development;... |
|
|
P/S
|
Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine ad... |
|
|
P/S
|
Human vaccines; vaccine adjuvants. Pharmaceutical, biologic, and vaccine research and development... |
